이노진

344860KOSDAQ

43.0 / 100

Reference Date: 2026-09-08

Financial Score13.5 / 40

News Sentiment12.5 / 25

Momentum5.0 / 20

Disclosure12.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Slightly up 1.4% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Inozen is a cosmeceutical company specializing in hair loss and problematic skin care, offering comprehensive solutions including home care, scalp devices, health supplements, and pharmaceuticals both domestically and internationally. In 2024, hair loss products accounted for 82% of sales, utilizing IIT (Initial Intensive Therapy) and DEDS (Different Etiology, Different Solution) systems for personalized treatment. Its skincare product line features mild, acidic pH formulations with soothing effects, under brands like Dr. Medition and Rescuvai.

Number of Employees

58people

Average Salary

40.8M KRW

Score Calculation Basis

Detailed Financial Score

PER

50.85Industry Average 15.000.0Point

3.4x industry avg (risky)

PBR

1.35Industry Average 1.202.5Point

Higher than industry avg (caution)

ROE

1.88Industry Average 8.001.0Point

Well below industry avg

Debt Ratio

0.13Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20252.0 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼9.8% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼73.9% (2-year basis)

ROE Trend

2.0 / 4

Avg ROE 6.6% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (11%, downtrend)

Current 1,322Won52-week high 2,25552-week low 1,206

1-month return3.0Point

1m 1.38% (flat)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

9 totalPositive 1Neutral 8Negative 0

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-25
Neutral주식등의대량보유상황보고서(일반)2026-08-24
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-24
Neutral증권발행결과(자율공시)2026-08-18
Neutral반기보고서 (2026.06)2026-08-14